Absence of Somatostatin Receptors in Human Exocrine Pancreatic Adenocarcinomas
- 1 September 1988
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 95 (3), 760-763
- https://doi.org/10.1016/s0016-5085(88)80025-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hormone-Producing Gastrointestinal Tumors Contain a High Density of Somatostatin ReceptorsJournal of Clinical Endocrinology & Metabolism, 1987
- Visualization of Somatostatin Receptors and Correlation with Immunoreactive Growth Hormone and Prolactin in Human Pituitary Adenomas: Evidence for Different Tumor SubclassesJournal of Clinical Endocrinology & Metabolism, 1987
- Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.Proceedings of the National Academy of Sciences, 1987
- Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue.BMJ, 1986
- Current status of chemotherapy for advanced pancreatic and gastric cancer.Journal of Clinical Oncology, 1985
- A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growthActa Endocrinologica, 1985
- Somatostatin: a potential antigrowth factor for the exocrine pancreasRegulatory Peptides, 1984
- Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.Proceedings of the National Academy of Sciences, 1984
- SPECIFIC HIGH AFFINITY BINDING SITES FOR SOMATOSTATIN-28 ON PANCREATIC 6-CELLS:DIFFERENCES WITH BRAIN SOMATOSTATIN RECEPTORS1Endocrinology, 1982
- The Effect of Somatostatin Analogs on Secretion of Growth, Pancreatic, and Gastrointestinal Hormones in ManJournal of Clinical Endocrinology & Metabolism, 1981